TVGN Tevogen Bio Holdings Inc.

company

SEC Filings & Insider Trading Activity 2026

Risk Factors

• • New risk: Nasdaq non-compliance due to Common Stock closing bid below $1.00 for 30+ days as of Sept 23, 2025
• • Material update: Nasdaq gives 180 days to regain $1.00 bid compliance, or risk delisting by March 23, 2026

What are the latest TVGN SEC filings in 2026?

Tevogen Bio Holdings Inc. (TVGN) has filed a 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 14, 2025, an 8-K current report on April 22, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did TVGN file its most recent 10-K annual report?

Tevogen Bio Holdings Inc. (TVGN) filed its most recent 10-K annual report on March 31, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view TVGN 10-Q quarterly reports?

Tevogen Bio Holdings Inc. (TVGN)'s most recent 10-Q quarterly report was filed on November 14, 2025. SignalX displays every TVGN 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has TVGN filed recently?

Tevogen Bio Holdings Inc. (TVGN)'s most recent 8-K was filed on April 22, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find TVGN insider trading activity (Form 4)?

SignalX aggregates every TVGN Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does TVGN file with the SEC?

Tevogen Bio Holdings Inc. (TVGN) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new TVGN filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Tevogen Bio Holdings Inc. (TVGN).

What is TVGN's SEC CIK number?

Tevogen Bio Holdings Inc. (TVGN)'s SEC CIK (Central Index Key) number is 1860871. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1860871 to look up all TVGN filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find TVGN return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Tevogen Bio Holdings Inc. (TVGN) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.